Home › Allergy › Tennessee › Nashville
Allergy clinical trials in Nashville, TN
5 studies for Allergy are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of Oral Food Challenge Biomarkers (SAFER)
RecruitingObservational study
- Vanderbilt University Medical Center: Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Nashville
Beginning to Assess an Appropriate CONtrol for Oral Food Challenges in Alpha-Gal Syndrome (CoFAR-13) - BeACON4AG
RecruitingPhase 2
- Vanderbilt University Medical Center: Division of Pediatric Allergy, Immunology, and Pulmonary Medicine, Nashville
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
RecruitingPhase 2
- Vanderbilt University Medical Center, Nashville
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RecruitingPhase 2
- Vanderbilt University Medical Center, Nashville
Sensory Symptoms in Tourette Syndrome
RecruitingObservational study
- Vanderbilt University Medical Center, Nashville
- Vanderbilt University Medical Center, Nashville
About Allergy
An allergy is a reaction by your immune system. Substances that cause reactions include pollen and food. Find the full list of allergies and symptoms.
More about Allergy on MedlinePlus
Allergy trials in other cities
- Boston, MA6 studies
- New York City, NY6 studies
- Washington, DC4 studies
- Ann Arbor, MI4 studies
- Mountain View, CA4 studies
- Cincinnati, OH3 studies
- Baltimore, MD3 studies
- Chicago, IL3 studies
- Durham, NC3 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer96 studies
- Breast Cancer79 studies
- Metastatic Cancer69 studies
- Colorectal Cancer68 studies
- Cancer (all types)64 studies
- Ovarian Cancer48 studies
- Prostate Cancer43 studies
- Pancreatic Cancer40 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Endometrial Cancer37 studies
- Melanoma32 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.